CANSINOBIO Shares Rise 8% in Early Trading Following Significant 94% Reduction in Interim Losses
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 21 2025
0mins
Source: aastocks
Stock Performance: CANSINOBIO (06185.HK) opened 2.2% higher at HKD48.46 and peaked at HKD51.8, closing at HKD51.3, an increase of 8.18%.
Short Selling Data: The company experienced short selling worth $3.94 million with a ratio of 3.914%.
Interim Results: The group reported interim revenue of RMB374 million, reflecting a year-on-year growth of 31.1%.
Loss Reduction: The company's loss significantly decreased from approximately RMB225 million to RMB13.485 million, marking a reduction of about 94%, with no dividend declared.
Analyst Views on 06185
Wall Street analysts forecast 06185 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 06185 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 38.780
Low
Averages
High
Current: 38.780
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
